Skip to content

Prostate Specific Antigen Levels of Individuals Living in Rural Areas

Prostate Specific Antigen Levels and Its Relationship With Some Characteristics in Individuals Living in Rural Areas: A Cross-Sectional Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06900348
Enrollment
308
Registered
2025-03-28
Start date
2025-03-25
Completion date
2025-08-30
Last updated
2025-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Carcinoma

Keywords

Prostate Carcinoma, Screening

Brief summary

It was planned in cross-sectional design in order to determine the specific prostate antigen level and some characteristics and the relationship evaluations and prostate specific antigen formation in individuals living in rural areas. It was planned to perform socio-demographic information formula, form including social information of health, prostate specific antigen test in the project data recording.

Detailed description

It was planned in a cross-sectional design to evaluate the prostate specific antigen level and its relationship with some characteristics in elderly individuals living in rural areas and to determine the prostate specific antigen level. The research area of the project consists of 8 villages. In the collection of project data, it was planned to conduct a socio-demographic feature information form, a form including social determinants of health, and a prostate specific antigen test. This planned project is the first research to be conducted in our country in terms of determining risky groups, ensuring randomness in participants, and sampling method for universe representation. In addition, screening the rural area, which is disadvantaged in terms of socio-economic and demographic aspects, and preferring elderly individuals constitute the steps taken to ensure health equality of the disadvantaged group in terms of health service transportation opportunities.

Interventions

DIAGNOSTIC_TESTPSA-Activated PSA-PAH1

Intravenous blood sample

Sponsors

Suleyman Demirel University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
55 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male * 55 years or older

Exclusion criteria

-Prostate treatment

Design outcomes

Primary

MeasureTime frameDescription
PSA levels6 monthsFor ages 60-69: 0 - 4.5 ng/ml, For ages 70 and above: 0 - 6.5 ng/ml

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026